Skip to main content
2024 CRT Conference Main banner
Back

CRT 2024

Innovation

BRS, DES and DCB Technologies [Non-CME]

Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final Five-Year Results of the AIDA Randomized Clinical Trial

Sunday, March 10, 2024
11:50 AM – 11:58 AM ET

    Speaker(s)

  • Ruben Yannick Gerold Tijssen, MD, PhD

    MD, PhD
    St. Antonius Ziekenhuis Nieuwegein / Academic Medical Center Amsterdam
    Naarden, Noord-Holland, Netherlands

    Disclosure(s): No financial relationships to disclose